Why are we asking you to sign in? Find out more here
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy .
Why are we asking you to sign in? Find out more here
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy .
UFC confirm Anderson Silva and Nick Diaz both failed UFC 183 drug tests
THE UFC HAS been hit by a fresh doping controversy after news emerged overnight that both Anderson Silva and Nick Diaz failed drug tests surrounding their UFC 183 bout on Saturday night.
In a statement on their website last night, the UFC confirmed they had been notified by the Nevada State Athletic Commission (NSAC) that Diaz has tested positive for marijuana metabolites following Saturday’s fight.
It also emerged that Silva tested positive for Drostanolone metabolites in an out of competition test on 9 January this year. The organisation went on to say they understood that further testing would be conducted by the NSAC to confirm the preliminary results.
Drostanolone is an anabolic steroid that is used in the treatment of cholesterol and some forms of cancer.
The UFC’s statement on the Brazilian said:
“The UFC has a strict, consistent policy against the use of any illegal and/or performance enhancing drugs, stimulants or masking agents by its athletes.”
This news comes in the wake of light heavyweight champion Jon Jones’ positive test for cocaine metabolites prior to UFC 182.
Cathal Pendred will fight next week if the UFC need a welterweight on short notice
10 of the best bits from tonight’s episode of the Conor McGregor documentary
To embed this post, copy the code below on your site
Anderson Silva Doping drugs in sport Nick Diaz Positive tests UFC UFC 183